Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina (Q37597055)

21 August 2017

1 reference

title

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina (English)

1 reference

21 August 2017

0 references

0 references

0 references

1

Sergio Sosa-Estani

1 reference

21 August 2017

Rodolfo Viotti

2

1 reference

PubMed ID

19753472

21 August 2017

Elsa Leonor Segura

series ordinal

3

1 reference

PubMed ID

19753472

21 August 2017

language of work or name

1 reference

1 July 2009

1 reference

Memórias do Instituto Oswaldo Cruz

21 August 2017

1 reference

21 August 2017

104 Suppl 1

1 reference

21 August 2017

167-180

1 reference

Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients.

21 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Chagas disease in bone marrow transplantation: an approach to preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Nova entidade morbida do homem: rezumo geral de estudos etiolojicos e clinicos

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Kinetoplastida: new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Assessment of chemiluminescence and PCR effectiveness in relation to conventional serological tests for the diagnosis of Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Ethiologic treatment of acute and chronic Chagas' Disease [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Chagasic antibodies induce cardiac COX-2/iNOS mRNA expression with PGE2/NO production

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Antiparasitic activity of risedronate in a murine model of acute Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Development and validation of a risk score for predicting death in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

21 January 2018

CHAGASIC MYOCARDIOPATHY.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Trypanosoma cruzi: specific detection of parasites by PCR in infected humans and vectors using a set of primers (BP1/BP2) targeted to a nuclear DNA sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

The need of a neonatal preparation for Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Malignant, non-Hodgkin's lymphomas in Trypanosoma cruzi-infected rabbits treated with nitroarenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Differential distribution of Trypanosoma cruzi clones in human chronic chagasic cardiopathic and non-cardiopathic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Exercise stress testing as a predictor of progression of early chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Parasite persistence correlates with disease severity and localization in chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Diagnóstico, manejo y tratamiento de la cardiopatía chagásica crónica en áreas donde la infección por Trypanosoma cruzi no es endémica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000900023

10.1590/S0074-02762009000900023

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19753472